Stephen G. Walsh

Array ( [id] => 2949219 [patent_doc_number] => 05242688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-07 [patent_title] => 'Method of treating thromboembolic disorders by administration of diglycosylated t-PA variants' [patent_app_type] => 1 [patent_app_number] => 7/633584 [patent_app_country] => US [patent_app_date] => 1990-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19865 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/242/05242688.pdf [firstpage_image] =>[orig_patent_app_number] => 633584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2889643 [patent_doc_number] => 05270197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-14 [patent_title] => 'Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor' [patent_app_type] => 1 [patent_app_number] => 7/631717 [patent_app_country] => US [patent_app_date] => 1990-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 14 [patent_no_of_words] => 7887 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/270/05270197.pdf [firstpage_image] =>[orig_patent_app_number] => 631717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2882976 [patent_doc_number] => 05268273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-07 [patent_title] => 'Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same' [patent_app_type] => 1 [patent_app_number] => 7/627539 [patent_app_country] => US [patent_app_date] => 1990-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13105 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/268/05268273.pdf [firstpage_image] =>[orig_patent_app_number] => 627539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2969505 [patent_doc_number] => 05202420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-13 [patent_title] => 'Tracheal antimicrobial peptides, DNA sequences and methods for the production and use thereof' [patent_app_type] => 1 [patent_app_number] => 7/603451 [patent_app_country] => US [patent_app_date] => 1990-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 8608 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/202/05202420.pdf [firstpage_image] =>[orig_patent_app_number] => 603451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2974692 [patent_doc_number] => 05194586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-16 [patent_title] => 'Anti-ATLA antibody binding peptides' [patent_app_type] => 1 [patent_app_number] => 7/596081 [patent_app_country] => US [patent_app_date] => 1990-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 15357 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 588 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/194/05194586.pdf [firstpage_image] =>[orig_patent_app_number] => 596081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2871000 [patent_doc_number] => 05153379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-06 [patent_title] => 'Shielded low-profile electronic component assembly' [patent_app_type] => 1 [patent_app_number] => 7/594448 [patent_app_country] => US [patent_app_date] => 1990-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 2134 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/153/05153379.pdf [firstpage_image] =>[orig_patent_app_number] => 594448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2841719 [patent_doc_number] => 05171837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-15 [patent_title] => 'Peptide capable of binding interleukin 6 and an adsorbent comprising the peptide immobilized on a carrier' [patent_app_type] => 1 [patent_app_number] => 7/582831 [patent_app_country] => US [patent_app_date] => 1990-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12662 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 458 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/171/05171837.pdf [firstpage_image] =>[orig_patent_app_number] => 582831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2976031 [patent_doc_number] => 05256642 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 7/588128 [patent_app_country] => US [patent_app_date] => 1990-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 81 [patent_no_of_words] => 45093 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256642.pdf [firstpage_image] =>[orig_patent_app_number] => 588128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2772402 [patent_doc_number] => 05075288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-24 [patent_title] => 'Somnogenic fragment of interleukin-1.beta.' [patent_app_type] => 1 [patent_app_number] => 7/577920 [patent_app_country] => US [patent_app_date] => 1990-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2920 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/075/05075288.pdf [firstpage_image] =>[orig_patent_app_number] => 577920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2890840 [patent_doc_number] => 05177002 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-05 [patent_title] => 'In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor' [patent_app_type] => 1 [patent_app_number] => 7/576248 [patent_app_country] => US [patent_app_date] => 1990-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 2 [patent_no_of_words] => 4711 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/177/05177002.pdf [firstpage_image] =>[orig_patent_app_number] => 576248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2785263 [patent_doc_number] => 05164483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-17 [patent_title] => 'Y-carboxyglutamate derivative, method for preparing the same and method for preparing human osteocalcin using the same' [patent_app_type] => 1 [patent_app_number] => 7/575639 [patent_app_country] => US [patent_app_date] => 1990-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10020 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/164/05164483.pdf [firstpage_image] =>[orig_patent_app_number] => 575639 [rel_patent_id] =>[rel_patent_doc_number] =>)